Efficacy of Botulinum Toxin A for Treatment of Upper Esophageal Sphincter Dysfunction

Abstract

Our results support the use of BTA in selected patients with pure UES dysfunction. Its efficacy is limited by the possibility of a persistent structural stenosis of the UES and the risk of BTA diffusion into the larynx or hypopharynx.